The community and clinical burdens of atrial fibrillation (AF) have been growing in recent years, with projections estimating sustained increases in the immediate future.
1-6 Multiple explanations have been posited for the AF increase, including an aging population, prolonged survival of individuals with cardiac conditions that predispose them to AF, and an increasing prevalence of AF risk factors, such as obesity and hypertension, in the at-risk populations.
3,5,7-15 Moreover, some authors have perceived increased attention being directed to AF in recent years—commonly attributed to the introduction of new anticoagulants for stroke prevention—that may be increasing the propensity to document AF clinically, especially as a secondary diagnosis.
14,16,17 Furthermore, prior studies have shown disproportionate increases in AF incidence by diagnostic setting (inpatient vs outpatient), although studies were discordant on the nature of these differences.
18,19 Lastly, increasing AF may be partially attributed to more frequent utilization of electrocardiography (ECG) in both routine clinical environments and through implanted or wearable devices with continuous AF-detecting capabilities, thereby increasing the opportunity to uncover AF.
3,7,9,10,14